Literature DB >> 1912133

Enzymes of the antioxidant defense system in chronic schizophrenic patients.

R Reddy1, M P Sahebarao, S Mukherjee, J N Murthy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1912133     DOI： 10.1016/0006-3223(91)90298-z

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  37 in total

Review 1.  Genetic association studies of antioxidant pathway genes and schizophrenia.

Authors:  Kodavali V Chowdari; Mikhil N Bamne; Vishwajit L Nimgaonkar
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

2.  Oxidative stress in schizophrenia: pathogenetic and therapeutic implications.

Authors:  Jeffrey K Yao; Ravinder Reddy
Journal:  Antioxid Redox Signal       Date:  2011-05-04       Impact factor: 8.401

3.  Oxidative stress in early stage Bipolar Disorder and the association with response to lithium.

Authors:  Rafael T de Sousa; Carlos A Zarate; Marcus V Zanetti; Alana C Costa; Leda L Talib; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  J Psychiatr Res       Date:  2013-12-06       Impact factor: 4.791

Review 4.  Oxidative stress in schizophrenia: an integrated approach.

Authors:  Byron K Y Bitanihirwe; Tsung-Ung W Woo
Journal:  Neurosci Biobehav Rev       Date:  2010-10-23       Impact factor: 8.989

5.  Fish oil and antipsychotic drug risperidone modulate oxidative stress in PC12 cell membranes through regulation of cytosolic calcium ion release and antioxidant system.

Authors:  Sevil Altinkiliç; Mustafa Naziroğlu; Abdülhadi Cihangir Uğuz; Ramazan Ozcankaya
Journal:  J Membr Biol       Date:  2010-06-24       Impact factor: 1.843

6.  Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview.

Authors:  D Metodiewa; C Kośka
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

7.  The neurotoxicity of glutamate, dopamine, iron and reactive oxygen species: functional interrelationships in health and disease: a review-discussion.

Authors:  J Smythies
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

8.  Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.

Authors:  Xiang Y Zhang; Da C Chen; Mei H Xiu; Fu D Yang; Yunlong Tan; Xingguang Luo; Lingjun Zuo; Therese A Kosten; Thomas R Kosten
Journal:  Schizophr Bull       Date:  2013-04-15       Impact factor: 9.306

Review 9.  Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia.

Authors:  Mohammad M Khan
Journal:  CNS Drugs       Date:  2016-07       Impact factor: 5.749

10.  Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons.

Authors:  Zhihong Jiang; Gregory R Rompala; Shuqin Zhang; Rita M Cowell; Kazu Nakazawa
Journal:  Biol Psychiatry       Date:  2013-01-21       Impact factor: 13.382
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.